HODGKIN DISEASE
Clinical trials for HODGKIN DISEASE explained in plain language.
Never miss a new study
Get alerted when new HODGKIN DISEASE trials appear
Sign up with your email to follow new studies for HODGKIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Donor immune cells show promise against Virus-Linked cancers
Disease control OngoingThis study tests whether specially trained immune cells from healthy donors can safely fight cancers and diseases caused by the Epstein-Barr virus (EBV). The cells are made quickly in the lab and stored in a bank, so they are ready for patients whose cancer has returned or not re…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New combo therapy shows promise for kids with advanced hodgkin lymphoma
Disease control OngoingThis study tested a new combination of a targeted drug (brentuximab vedotin) with standard chemotherapy in 59 children and teens with advanced, newly diagnosed Hodgkin lymphoma. The goal was to find the safest dose and see how well the treatment shrinks tumors. Early results sugg…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Acupuncture may slash opioid use in cancer patients during chemo
Symptom relief OngoingThis study looks at whether adding acupuncture to standard pain care can reduce the need for strong opioid painkillers in people with multiple myeloma, Hodgkin disease, or non-Hodgkin lymphoma who are getting high-dose chemotherapy. About 299 adults will be randomly assigned to r…
Matched conditions: HODGKIN DISEASE
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:51 UTC
-
New study monitors cancer survivors for hidden After-Effects of treatment
Knowledge-focused OngoingThis study follows 500 adults aged 18-65 who finished chemotherapy for certain cancers and are in remission. Over 5 years, researchers will check for 19 possible late side effects like heart problems, memory issues, and fatigue. The goal is to catch these problems early and impro…
Matched conditions: HODGKIN DISEASE
Phase: NA • Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated May 26, 2026 06:09 UTC
-
Scientists hunt for hidden causes of blood cancers in High-Risk families
Knowledge-focused OngoingThis study looks at people and families who may be more likely to develop blood or lymph node cancers, such as leukemia or lymphoma. Researchers want to learn about the genetic and environmental factors that raise cancer risk. Participants fill out health questionnaires and provi…
Matched conditions: HODGKIN DISEASE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC